Results 111 to 120 of about 1,629 (148)

Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

Int J Mol Sci
Galati D, Zanotta S, Florio F, Mele S, De Filippi R, Pinto A.   +5 more
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: Two case reports. [PDF]

World J Clin Oncol
Ma YQ, Sun Z, Li YM, Xu H.
europepmc   +1 more source

Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene. [PDF]

Cancer Cell Int
Li R, Kuang W, Yang H, Zhang B, Zhao K, Fang W, Cheng Z, Fu X, Peng H.   +8 more
europepmc   +1 more source

First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial. [PDF]

Br J Haematol
Stein AS, Lane AA, Sweet KL, Vasu S, Tosolini A, Katsetos J, Konopleva M, Pemmaraju N.   +7 more
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report of a Rare and Aggressive Hematologic Malignancy. [PDF]

Cureus
Saha K, Thoram GSK, Roychoudhury S.
europepmc   +1 more source

Radiation Therapy for Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report and Review of the Literature. [PDF]

Curr Oncol
Taka M, Toyoshima S, Takamatsu S, Kobayashi S.   +3 more
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View. [PDF]

Int J Mol Sci
Di Raimondo C, Lozzi F, Di Domenico PP, Paganini C, Campione E, Galluzzo M, Bianchi L.   +6 more
europepmc   +1 more source

Localized blastic plasmacytoid dendritic cell neoplasm associated with progressive clonal hematopoiesis and myelodysplastic syndrome. [PDF]

APMIS
Julin C, Nielsen SL, Grantzau TL, Ahmad SA, Cowland JB, Bonde J, Nørgaard P.   +6 more
europepmc   +1 more source

Tagraxofusp maintenance post-hematopoietic stem cell transplantation provides long-term survival and manageable safety for a patient with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Leuk Res Rep
Bashir Q, Konopleva M, Abueg G, Ramdial J, Hosing C, Srour SA, Alousi A, Popat UR, Nieto Y, Alatrash G, Champlin RE, Shpall EJ, Qazilbash M, Pemmaraju N.   +13 more
europepmc   +1 more source